Indriķis
Liepa
Partner / Latvia
 
about

Indriķis Liepa heads IP, IT and Regulatory practice group and is among the leading practitioners in pharmacy law. He has a vast track record of over 15 years in consulting the leading local and foreign financial, food production, IT and other companies. Indrikis has substantial skills base in arranging major local M&A deals and significant investment projects.

Indriķis has extensive knowledge on pharmacy law and is rendering both - daily legal support to numerous pharmacy undertakings and has also advised on major pharmaceutical industry headline deals.

 
recognition
  • Corporate/Commercial – Band 4, Chambers Global 2021
  • Corporate/Commercial – Band 4, Chambers Europe 2021
 
cv
Languages
Latvian, English, Russian

Education & membership
  • Master’s degree in Law, Riga Graduate School of Law, Riga, Latvia (2003)
  • Lawyer’s qualification,  University of Latvia, Riga, Latvia (2002)
  • Latvian Bar Association (since 2002)
  • Institute for Corporate Sustainability and Responsibility
  • International Association of Young Lawyers
  • OECD Latvian task group


Publications
Load More
 
experience
Load More
  • 2015 — 04 — 14
    Representation of Abbott Laboratories Baltics
  • 2015 — 03 — 18
    COBALT advises H&M on Latvian tax matters
  • 2015 — 03 — 10
    General legal assistance to Mylan
  • 2015 — 03 — 04
    Legal assistance to Nordic Sugar AS
  • 2015 — 02 — 27
    General legal assistance to GlaxoSmithKline
  • 2015 — 02 — 11
    COBALT advises Abbott Laboratories on sale to Mylan of non-U.S. developed markets specialty and branded generics business
  • 2015 — 02 — 05
    General legal assistance to Roche
  • 2015 — 01 — 28
    COBALT advises Association of Biopharmaceutical Medicinal Products in Latvia (includes AbbVie, Merck Serono, Roche and others) on amendments to legal pharma-regulations
  • 2015 — 01 — 22
    General legal assistance to Abbott Laboratories
  • 2015 — 01 — 08
    General legal assistance to Abbvie
  • 2014 — 11 — 21
    COBALT advises Franklin Templeton Investments in acquisition of majority stake in SIA Storent Holding
  • 2014 — 10 — 30
    COBALT advises Merck & Co., Inc in sale of Merck’s consumer care business
  • 2014 — 08 — 28
    COBALT represents minority shareholder interests in acquisition of 60% stake in Ask.fm by Dutch company IAC Search Europe B.V.
  • 2014 — 08 — 04
    Legal advice to Roche Latvia on implementation of a distribution scheme
  • 2014 — 06 — 09
    COBALT provides legal assistance to SIA FMS on company sale to major North European IT company Visma Group
  • 2014 — 03 — 28
    COBALT advises Wikimedia on Latvian tax matters
  • 2014 — 03 — 06
    Tax advice to Homburg Invest Inc. in global corporate restructuring process
  • 2014 — 03 — 04
    COBALT advises Canadian stock listed company within implementation of a restructuring plan governed under Canadian CCAA rules in the Baltics
  • 2013 — 11 — 15
    COBALT advises Association for Lymphoma Patients’ Support and the Rare Disease Association Caladrius
  • Indriķis Liepa frequently assists clients from a range of sectors with M&A transactions. He is particularly known for his expertise in pharmaceutical law. Clients describe him as ‘business-minded.’
    Chambers Global 2020, Corporate/Commercial